MedTrace Logo

The Spanish Familial Hypercholesterolaemia Cohort Study

NCT02693548 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4141

Last updated 2025-02-28

No results posted yet for this study

Summary

SAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.

Conditions

  • Familial Hypercholesterolaemia

Sponsors & Collaborators

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    collaborator OTHER

  • Fundación Hipercolesterolemia Familiar

    lead OTHER

Principal Investigators

  • Pedro Mata, MD · Fundacion Hipercolesterolemia Familiar

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2030-10-31
Completion
2030-10-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693548 on ClinicalTrials.gov